Use of Vascade Vascular Closure System for Venous Hemostasis

Arun Nagabandi, Supawat Ratanapo, Loren Garrison Morgan, Deepak Kapoor

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Access-site complications remain the most common complication from cardiac catheterization procedures, with reported incidence of 2%-3% in the current era. With the growing number of patients on chronic anticoagulation and antiplatelet medications who require venous access for cardiac procedures, we proposed that vascular closure devices (selected for characteristics optimal for venous closure) could deliver a safe and effective way to achieve rapid hemostasis, while also allowing for earlier ambulation times and shorter stays.

Original languageEnglish (US)
Pages (from-to)E171-E173
JournalVascular Disease Management
Volume14
Issue number8
StatePublished - Aug 1 2017

Fingerprint

Hemostasis
Blood Vessels
Early Ambulation
Cardiac Catheterization
Incidence
Vascular Closure Devices

Keywords

  • hemostasis
  • vascular closure device

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Nagabandi, A., Ratanapo, S., Morgan, L. G., & Kapoor, D. (2017). Use of Vascade Vascular Closure System for Venous Hemostasis. Vascular Disease Management, 14(8), E171-E173.

Use of Vascade Vascular Closure System for Venous Hemostasis. / Nagabandi, Arun; Ratanapo, Supawat; Morgan, Loren Garrison; Kapoor, Deepak.

In: Vascular Disease Management, Vol. 14, No. 8, 01.08.2017, p. E171-E173.

Research output: Contribution to journalArticle

Nagabandi, A, Ratanapo, S, Morgan, LG & Kapoor, D 2017, 'Use of Vascade Vascular Closure System for Venous Hemostasis', Vascular Disease Management, vol. 14, no. 8, pp. E171-E173.
Nagabandi A, Ratanapo S, Morgan LG, Kapoor D. Use of Vascade Vascular Closure System for Venous Hemostasis. Vascular Disease Management. 2017 Aug 1;14(8):E171-E173.
Nagabandi, Arun ; Ratanapo, Supawat ; Morgan, Loren Garrison ; Kapoor, Deepak. / Use of Vascade Vascular Closure System for Venous Hemostasis. In: Vascular Disease Management. 2017 ; Vol. 14, No. 8. pp. E171-E173.
@article{db6440b7066e4c63a32dcfaaff313dc8,
title = "Use of Vascade Vascular Closure System for Venous Hemostasis",
abstract = "Access-site complications remain the most common complication from cardiac catheterization procedures, with reported incidence of 2{\%}-3{\%} in the current era. With the growing number of patients on chronic anticoagulation and antiplatelet medications who require venous access for cardiac procedures, we proposed that vascular closure devices (selected for characteristics optimal for venous closure) could deliver a safe and effective way to achieve rapid hemostasis, while also allowing for earlier ambulation times and shorter stays.",
keywords = "hemostasis, vascular closure device",
author = "Arun Nagabandi and Supawat Ratanapo and Morgan, {Loren Garrison} and Deepak Kapoor",
year = "2017",
month = "8",
day = "1",
language = "English (US)",
volume = "14",
pages = "E171--E173",
journal = "Vascular Disease Management",
issn = "1553-8036",
publisher = "HMP Communications",
number = "8",

}

TY - JOUR

T1 - Use of Vascade Vascular Closure System for Venous Hemostasis

AU - Nagabandi, Arun

AU - Ratanapo, Supawat

AU - Morgan, Loren Garrison

AU - Kapoor, Deepak

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Access-site complications remain the most common complication from cardiac catheterization procedures, with reported incidence of 2%-3% in the current era. With the growing number of patients on chronic anticoagulation and antiplatelet medications who require venous access for cardiac procedures, we proposed that vascular closure devices (selected for characteristics optimal for venous closure) could deliver a safe and effective way to achieve rapid hemostasis, while also allowing for earlier ambulation times and shorter stays.

AB - Access-site complications remain the most common complication from cardiac catheterization procedures, with reported incidence of 2%-3% in the current era. With the growing number of patients on chronic anticoagulation and antiplatelet medications who require venous access for cardiac procedures, we proposed that vascular closure devices (selected for characteristics optimal for venous closure) could deliver a safe and effective way to achieve rapid hemostasis, while also allowing for earlier ambulation times and shorter stays.

KW - hemostasis

KW - vascular closure device

UR - http://www.scopus.com/inward/record.url?scp=85032740666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032740666&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85032740666

VL - 14

SP - E171-E173

JO - Vascular Disease Management

JF - Vascular Disease Management

SN - 1553-8036

IS - 8

ER -